Taek W. Kang
Gwangju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial.
Journal: BJU international
Published: February 10, 2026
Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial.
Journal: BJU international
Published: February 10, 2026
Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 15, 2026
Assessment of Residual Cortical Function by Using Tc-99m DMSA SPECT at Follow-Up in Non-Operatively Treated Patients with Traumatic Renal Injuries: A Prospective Single-Centre Study.
Journal: Journal of clinical medicine
Published: July 14, 2025
Neuroprotective effects of Gnetin H from Paeonia lactiflora via CREB-BDNF pathway restoration in a scopolamine-induced memory deficit model.
Journal: European journal of pharmacology
Published: April 18, 2025
The prevalence of dyslipidemia in patients with prostate cancer.
Journal: Prostate international
Published: December 13, 2024
Uncaria Rhynchophylla and hirsuteine as TRPV1 agonists inducing channel desensitization.
Journal: Journal of ethnopharmacology
Published: September 05, 2024
Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea.
Journal: Prostate international
Published: August 29, 2024
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia.
Journal: Prostate international
Published: July 10, 2024
Identification of an Antagonist Targeting G Protein and β-Arrestin Signaling Pathways of 5-HT7R.
Journal: ACS chemical neuroscience
Published: February 22, 2024
FGFR3 Mutations in Urothelial Carcinoma: A Single-Center Study Using Next-Generation Sequencing.
Journal: Journal of clinical medicine
Published: January 20, 2024
Discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for treating cancers with microsatellite instability.
Journal: Bioorganic & medicinal chemistry
Published: October 05, 2023
Last Updated: 09/26/2026